Role of Endothelial Function in SCI CVD Risk
Craig Hospital · with University of Colorado, Boulder · NCT06443151
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–89 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- September 1, 2024
- Record last updated
- August 20, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Individuals with spinal cord injury have heart attacks and strokes more frequently, and much earlier in life. People with spinal cord injuries develop plaque in vessels much faster, and the reasons why are unclear. Doctors generally attributed the increased risk with weight gain and developing diabetes, but many studies have shown that even without these common factors, plaque in vessels is developing more often and faster. Endothelial cells are a single layer of cells that line all vessels in the body and plays an important role in vessel health. Damage to endothelial cells is known to lead to heart attacks and strokes. Past studies on endothelial cells of people with spinal cord injury have been unclear. The investigators have new data that these cells are unhealthy after spinal cord injury a measurement. This includes measuring endothelial health by directly altering its function using a catheter in the arm and measuring small particles in blood called endothelial microvesicles. If the project is successful, the investigators will learn important information on the health of endothelial cells after spinal cord injury. The investigators will also be able to use these markers of endothelial cell function to create treatments to improve vessel health and prevent heart attacks and strokes later in life in people with spinal cord injury.
Being studied: Brachial intra-arterial infusion of vasoactive and antioxidant drugs (acetylcholine, nitroprusside, ascorbic acid); venous occlusion plethysmography; Acetylcholine; Sodium Nitroprusside; Ascorbic acid; venous phlebotomy
Conditions: Spinal Cord Injuries; Cardiovascular Diseases; Endothelial Dysfunction
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Men and women of all races, ethnic backgrounds>18 years of age
- Traumatic spinal cord injury (Sports, Assault, Transport, Fall, Other Traumatic Causes)
- Time since injury (> 12 months)
- Paraplegia Motor Complete Injury (neurological level of injury at T2 or below, ASIA Impairment Scale A or B
Exclusion Criteria
- History of high blood pressure
- History cardiovascular disease (coronary artery disease, congestive heart failure, myocardial infarction, cerebrovascular accident).
- History high cholesterol
- History of Diabetes Type I or Type II
- History of Obstructive Pulmonary Disease
- History of Chronic Kidney or Liver Disease
- History of Cancer
- History of Autoimmune Disease (Thyroid Disease, Lupus, Rheumatoid Arthritis, etc).
- History of smoking tobacco in the last 12 months
- History of alcohol use
Recruiting US locations
Craig Hospital
Englewood, CO 80113
Site contact: Clare Morey, SLP-CCC · 303-789-8621 · cmorey@craighospital.org
Study contacts (from the official record)
- Clare Morey, SLP-CCC · 303-789-8621 · cmorey@craighospital.org
- Andrew Park, MD · 303-789-8101 · apark@craighospital.org
Similar studies in Colorado
All heart & blood pressure studies in Colorado →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Aurora, CO + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteers
OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device
Aktiia SA
- Location
- Broomfield, CO
- Eligibility basics
- Ages 22–59
- RecruitingHealthy volunteers
Longevity Metrics AI/ML Development Study
Longevity Metrics, Inc.
- Location
- Boulder, CO
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
100-Year Human Aging Study
Longevity Metrics, Inc.
- Location
- Boulder, CO
- Eligibility basics
- Ages 18+